Should anticancer drug doses be adjusted in the obese patient?

Sharyn D. Baker; Louise B. Grochow; Ross C. Donehower

doi:10.1093/jnci/87.5.333

Should anticancer drug doses be adjusted in the obese patient?

Sharyn D. Baker, Louise B. Grochow, Ross C. Donehower

School of Medicine

Research output: Contribution to journal › Editorial › peer-review

29 Scopus citations

Original language	English (US)
Pages (from-to)	333-334
Number of pages	2
Journal	Journal of the National Cancer Institute
Volume	87
Issue number	5
DOIs	https://doi.org/10.1093/jnci/87.5.333
State	Published - Mar 1 1995

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1093/jnci/87.5.333

Cite this

@article{eb8cc08a40d24d04a0ee7ac255dc905f,

title = "Should anticancer drug doses be adjusted in the obese patient?",

author = "Baker, {Sharyn D.} and Grochow, {Louise B.} and Donehower, {Ross C.}",

year = "1995",

month = mar,

day = "1",

doi = "10.1093/jnci/87.5.333",

language = "English (US)",

volume = "87",

pages = "333--334",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",